U.S. Congress legislation · 119th Congress
HB5239: Endometrial Cancer Research and Education Act of 2025
Status: In committee, September 9, 2025
To amend the Public Health Service Act to expand research and education with respect to endometrial cancer, and for other purposes.
What the bill says
To amend the Public Health Service Act to expand research and education with respect to endometrial cancer, and for other purposes.
From the introduced text, September 9, 2025:
A BILL To amend the Public Health Service Act to expand research and education with respect to endometrial cancer, and for other purposes. SECTION 1. Short title This Act may be cited as the Endometrial Cancer Research and Education Act of 2025 . SECTION 2. Findings Congress finds the following: (1) Endometrial cancer is cancer of the lining of the uterus (or endometrium) and is the most common form of uterine cancer. (2) Endometrial cancer is the fourth most common cancer diagnosed in women, after breast, lung, and colon cancer. (3) Endometrial cancer mainly affects postmenopausal women, with most women diagnosed between age 55 and 64. (4) Women with polycystic ovary syndrome (PCOS) and uterine leiomyoma have an increased risk of developing endometrial cancer. (5) Unlike most other types of cancer, the incidence of endometrial cancer, particularly aggressive subtypes of such cancer, has been increasing in the United States among all women, particularly among African-American and Asian women, with a 2.5 annual percent change for both groups. (6) In comparison to non-Hispanic White women, African-American women have significantly higher incidence rates of aggressive endometrial cancers. (7) Such incidence rates for Hispanic and Asian women are equal to or lower than such incidence rates for non-Hispanic White women. (8) Although non-Hispanic White women are more likely to be diagnosed with endometrial …
Sponsors
- David Scott (D, HD-GA-13) · primary sponsor
- Yvette Clarke (D, HD-009)
- Shontel Brown (D, HD-011)
- Mike Johnson (R, HD-004)
- Gwen Moore (D, HD-004)
- Norton, Eleanor (D, HD-000)
- Terri Sewell (D, HD-007)
- Paul Tonko (D, HD-020)
- Henry Johnson (D, HD-004)
- Shri Thanedar (D, HD-013)
Latest actions
- : Referred to the House Committee on Energy and Commerce.
- : Introduced in House
Subjects: Health
Common questions
- What is HB5239?
- HB5239 is a bill in Congress (119th Congress): Endometrial Cancer Research and Education Act of 2025.
- What does HB5239 do?
- In its own words: To amend the Public Health Service Act to expand research and education with respect to endometrial cancer, and for other purposes.
- What is the status of HB5239?
- In committee as of September 9, 2025. Latest action: Referred to the House Committee on Energy and Commerce. (September 9, 2025).
- Who sponsored HB5239?
- David Scott (D, HD-GA-13), with 9 co-sponsors.
- Where is the official record for HB5239?
- On the Congress website: https://www.congress.gov/bill/119th-congress/house-bill/5239
Source: official Congress record. Tracked by Delilah, AI for legislation across all 50 states and Congress.